App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients
Conditions: Cancer Sponsors: Daynamica, Inc.; Masonic Cancer Center, University of Minnesota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
Conditions: Breast Cancer; Lung Cancer; Melanoma; Head and Neck Cancer; Urothelial Carcinoma; Colorectal Cancer; Liver Metastases; Lung Metastases Interventions: Genetic: Cohort A: primarily operable disease, candidate to adjuvant; Genetic: Cohort B: locally advanced disease; Genetic: Cohort C: metastatic disease; Genetic: Cohort D: Progressive disease; Genetic: Cohort E: Hematological neoplasms; Genetic: Cohort F: Toxicity Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
Conditions: Mild Allergic Asthma Interventions: Other: allergen challenge Sponsors: Fraunhofer-Institute of Toxicology and Experimental Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

Anesthesia Neurodevelopmental Impact in Congenital Scoliosis Children
Conditions: General Anesthetics Toxicity Interventions: Procedure: General anesthesia Sponsors: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials

The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
Conditions: Thymus Epithelial Tumor; Proton Radiotherapy; Radiation Toxicity Interventions: Radiation: Proton radiotherapy; Other: combined platinum based chemotherapy Sponsors: Jian Chen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients
Conditions: Cisplatin Adverse Reaction; Cisplatin Nephrotoxicity; Cisplatin Induced Peripheral Neuropathy; Cancer Patients; Cisplatin Ototoxicity Interventions: Drug: N acetyl cysteine Sponsors: Ain Shams University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation
Conditions: Allogeneic Stem Cell Transplantation Interventions: Drug: ASTX727; Drug: Donor Lymphocyte Infusion Sponsors: M.D. Anderson Cancer Center; Astex Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
Conditions: Tobacco Use; Cigarette Smoking; Nicotine Dependence Interventions: Other: Cigarettes Sponsors: Masonic Cancer Center, University of Minnesota; National Institutes of Health (NIH) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials

Brentuximab Vedotin Combined With Bendamustine Supercharge, a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma: Long-term Results of a Retrospective Monocenter Study.
Conditions: Hodgkin Lymphoma Interventions: Other: observational Sponsors: Federico II University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials

Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma; Efficacy; Toxicity Interventions: Drug: Induction Immunotherapy-Toripalimab; Drug: Induction Chemotherapy-Albumin-paclitaxel combined with cisplatin; Radiation: Radiotherapy; Drug: Apatinib; Drug: Capecitabine Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
Conditions: Non-small Cell Lung Cancer; Cardiac Toxicity Interventions: Other: Impedance cardiography Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials

Efficacy of Structured SOcial COnsultation and Support in Reducing the FINancial Burden of Radiotherapy
Conditions: Financial Toxicity Interventions: Other: Questionnaire Sponsors: University Medical Center Goettingen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials

Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
Conditions: Sarcopenia; Oncology; Physical Inactivity; Toxicity Due to Chemotherapy Interventions: Diagnostic Test: Sarcopenia diagnostic test Sponsors: Centre Hospitalier Metropole Savoie; Universit é Savoie Mont Blanc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Effects of Exercise Training in Survivors of Lymphoma
Conditions: Lymphoma; Physical Exercise; Cardiotoxicity; Cardiovascular Diseases; Chemotherapeutic Toxicity Interventions: Behavioral: Aerobic Exercise; Behavioral: Combined Aerobic and Resistance Exercise Sponsors: Norwegian School of Sport Sciences; Uppsala University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML
Conditions: MDS; CMML Sponsors: European Society for Blood and Marrow Transplantation; Novartis Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials